Gladstone Institutional Advisory LLC Novavax Inc Transaction History

Gladstone Institutional Advisory LLC

  • $2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$112.98 - $319.93 $271,716 - $769,431
-2,405 Closed
0 $0
Q4 2020

Jan 27, 2023
SELL
$78.74 - $139.5 $65,432 - $115,924
-831 Reduced 25.68%
2,405 $268,000
Q4 2020

Feb 16, 2021
SELL
$78.74 - $139.5 $65,432 - $115,924
-831 Reduced 25.68%
2,405 $268,000
Q3 2020

Jan 27, 2023
BUY
$79.44 - $178.51 $257,067 - $577,658
3,236 New
3,236 $351,000
Q3 2020

Nov 16, 2020
BUY
$79.44 - $178.51 $257,067 - $577,658
3,236 New
3,236 $351,000

Others Institutions Holding NVAX

# of Institutions
291
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $704M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email